Most importantly, these studies compile evidence that the accumulation of different DPRs in different brain regions during the progression of the disease could explain the dynamics contributing to the neurodegeneration seen in C9orf72-ALS/FTD patients. This evidence concerns the gene C9orf72 and frontotemporal dementia.